SCHEMBL4351690

SCHEMBL4351690

Cc1ccc2ccccc2c1CN

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.60
KDM4E B2RXH2 2/20 0.60
MAPT P10636 2/20 0.60
GAA P10253 1/20 0.60
TAAR1 Q96RJ0 1/20 0.60
HTR2A P28223 1/20 0.57
TSHR P16473 5/20 0.54
CYP1A2 P05177 4/20 0.54
CYP2A6 P11509 3/20 0.54
HSD17B10 Q99714 4/20 0.44
TDP1 Q9NUW8 2/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.43
SLC6A4 P31645 1/20 0.41
HPGD P15428 2/20 0.41
HPRT1 P00492 1/20 0.41
CYP3A4 P08684 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6251241 0.98 ALDH1A1 (0.58) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL6249203 0.83 TSHR (0.58) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL16042478 0.83 TSHR (0.58) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL6677013 0.82 HTR2A (0.57) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL607362 0.81 CYP1A2 (0.56) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL29489290 0.81 TSHR (0.56) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL29489289 0.81 TSHR (0.56) ALDH1A1KDM4EMAPTGAATAAR1
Potassium SCHEMBL29978462 0.81 TSHR (0.56) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL1538534 0.79 TSHR (0.54) ALDH1A1KDM4EMAPTGAATAAR1
SCHEMBL821213 0.79 TSHR (0.54) ALDH1A1KDM4EMAPTGAATAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002002503-A1 PROCESS FOR PREPARATION OF TERBINAFINE AND ITS HYDROCHLORIDE AS AN ANTIFUNGAL AGENT CHEMTECH RESEARCH INCORPORATION (KR) 2002-01-10 WO claimed
WO-2020264499-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed
EP-3655398-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS Phenex-FXR GmbH (DE) 2020-05-27 EP disclosed
US-20200131144-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS PHENEX-FXR GMBH (DE) 2020-04-30 US disclosed
CN-110914248-A LXR modulators containing amines or (thio) amides 菲尼克斯-FXR股份有限公司 2020-03-24 CN disclosed
WO-2019016269-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS PHENEX-FXR GMBH (DE) 2019-01-24 WO disclosed
EP-2657214-B1 PROCESS FOR PRODUCTION OF AROMATIC ALCOHOL OR HETEROCYCLIC AROMATIC ALCOHOL MITSUBISHI GAS CHEMICAL CO (JP) 2017-02-15 EP disclosed
EP-3113857-A1 CHROMATOGRAPHIC MATERIALS FOR THE SEPARATION OF UNSATURATED MOLECULES Waters Technologies Corporation (US) 2017-01-11 EP disclosed
CN-104055756-B The derivant of naftifine hydrochloride, Preparation method and use 中国科学院上海药物研究所 2016-10-05 CN disclosed
WO-2015134317-A9 CHROMATOGRAPHIC MATERIALS FOR THE SEPARATION OF UNSATURATED MOLECULES WATERS TECHNOLOGIES CORPORATION (US) 2016-08-04 WO disclosed
US-6452001-B2 1,4-DIAZEPINE-2-ONE DERIVATIVES AS NEUROKININ ANTAGONIST HOFFMANN-LA ROCHE INC. 2002-09-17 US disclosed
US-20020010174-A1 Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation F. HOFFMANN-LA ROCHE AG (CH) 2002-01-24 US disclosed
WO-2002002503-A1 PROCESS FOR PREPARATION OF TERBINAFINE AND ITS HYDROCHLORIDE AS AN ANTIFUNGAL AGENT CHEMTECH RESEARCH INCORPORATION (KR) 2002-01-10 WO disclosed
WO-2001090083-A1 1,4-DIAZEPAN-2,5-DIONE DERIVATIVES AND THEIR USE AS NK-1 RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2001-11-29 WO disclosed
WO-2001077064-A1 METHOD FOR THE PREPARATION OF (E)-N-(6,6-DIMETHYL-2-HEPTEN-4-YNYL)-N-METHYL-1-NAPHTHALENEMETHANAMINE (TERBINAFINE) SLOVAKOFARMA A.S. (SK) 2001-10-18 WO disclosed
EP-1077962-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services (US) 2001-02-28 EP disclosed
WO-1999058517-A2 ISOCYANATE DERIVATIZING AGENT AND METHODS OF PRODUCTION AND USE THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 1999-11-18 WO disclosed
EP-0753003-A1 AZIRIDINE DERIVATIVES, THEIR PRODUCTION AND USE Takeda Chemical Industries, Ltd. (JP) 1997-01-15 EP disclosed
WO-1995028416-A1 AZIRIDINE DERIVATIVES, THEIR PRODUCTION AND USE TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1995-10-26 WO disclosed
EP-0617002-A1 Process for preparing naphthalenepolycarboxylic acids BAYER AG (DE) 1994-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131144-A1 AMINE OR (THIO)AMIDE CONTAINING LXR MODULATORS NR1H2, NR1H3, NR1H4 ALDH1A1 2016/4885KDM4E 2569/4885MAPT 3356/4885
US-20020010174-A1 Diazapane derivatives useful as antagonists of neurokinin 1 receptor and methods for their formation BDKRB2, NPSR1, BDKRB1 ALDH1A1 1088/4885KDM4E 3134/4885MAPT 4885/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.